Share on StockTwits

Fluidigm (NASDAQ:FLDM) issued its quarterly earnings data on Thursday. The company reported ($0.45) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.50) by $0.05, Stock Ratings Network reports. The company had revenue of $27.60 million for the quarter, compared to the consensus estimate of $27.13 million. During the same quarter last year, the company posted ($0.07) earnings per share. Fluidigm’s revenue was up 57.7% compared to the same quarter last year.

Fluidigm (NASDAQ:FLDM) traded down 4.92% on Thursday, hitting $28.63. The stock had a trading volume of 501,837 shares. Fluidigm has a 52 week low of $18.52 and a 52 week high of $49.46. The stock’s 50-day moving average is $29.10 and its 200-day moving average is $36.5. The company’s market cap is $803.4 million.

FLDM has been the subject of a number of recent research reports. Analysts at Piper Jaffray reiterated an “overweight” rating on shares of Fluidigm in a research note on Tuesday, May 6th. They now have a $50.00 price target on the stock, down previously from $51.00. On a related note, analysts at Maxim Group cut their price target on shares of Fluidigm from $65.00 to $52.00 in a research note on Tuesday, May 6th. They now have a “buy” rating on the stock. Finally, analysts at Leerink Swann cut their price target on shares of Fluidigm from $52.00 to $48.00 in a research note on Tuesday, May 6th. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $44.76.

Fluidigm Corporation (NASDAQ:FLDM) develops, manufactures and markets microfluidic systems such as single-cell genomics, applied genotyping and sample preparation for targeted resequencing, in the life science and agricultural biotechnology, or Ag-Bio, industries.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.